These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17465715)

  • 21. Topic maps for exploring nosological, lexical, semantic and HL7 structures for clinical data.
    Paterson GI; Grant AM; Soroka SD
    Health Informatics J; 2008 Dec; 14(4):267-78. PubMed ID: 19008277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic opportunities and challenges for pharmacogenomics.
    Deverka PA; Vernon J; McLeod HL
    Annu Rev Pharmacol Toxicol; 2010; 50():423-37. PubMed ID: 20055709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An 'Honest Broker' mechanism to maintain privacy for patient care and academic medical research.
    Boyd AD; Hosner C; Hunscher DA; Athey BD; Clauw DJ; Green LA
    Int J Med Inform; 2007; 76(5-6):407-11. PubMed ID: 17081800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facilitating data exchange.
    Scalia K
    Behav Healthc; 2009 Feb; 29(2):30-1. PubMed ID: 19354128
    [No Abstract]   [Full Text] [Related]  

  • 25. Can a large institution go paperless?
    Sands DZ; Rind DM; Vieira C; Safran C
    Stud Health Technol Inform; 1998; 52 Pt 1():60-3. PubMed ID: 10384420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The making and adoption of health data standards.
    Hammond WE
    Health Aff (Millwood); 2005; 24(5):1205-13. PubMed ID: 16162564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protecting privacy while sharing medical data between regional healthcare entities.
    Grandison T; Ganta SR; Braun U; Kaufman J
    Stud Health Technol Inform; 2007; 129(Pt 1):483-7. PubMed ID: 17911764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Data elements for emergency department systems, release 1.0 (DEEDS): a summary report. DEEDS Writing Committee.
    Pollock DA; Adams DL; Bernardo LM; Bradley V; Brandt MD; Davis TE; Garrison HG; Iseke RM; Johnson S; Kaufmann CR; Kidd P; Leon-Chisen N; MacLean S; Manton A; McClain PW; Michelson EA; Pickett D; Rosen RA; Schwartz RJ; Smith M; Snyder JA; Wright JL
    Ann Emerg Med; 1998 Feb; 31(2):264-73. PubMed ID: 9472191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Legal implications of pharmacogenomics regarding drug trials, drug labeling, and genetic testing for drug prescription: an international approach.
    Mandry T
    Food Drug Law J; 2004; 59(4):519-35. PubMed ID: 15875348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virtual health platform for medical tourism purposes.
    Martinez D; Ferriol P; Tous X; Cabrer M; Prats M
    Stud Health Technol Inform; 2008; 137():269-74. PubMed ID: 18560088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HITSP working to harmonize. The national data exchange group is making tough decisions to provide the industry with a sound set of standards.
    Foxhall K
    Healthc Inform; 2006 Sep; 23(9):28. PubMed ID: 17001954
    [No Abstract]   [Full Text] [Related]  

  • 32. Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe.
    van den Akker-van Marle ME; Gurwitz D; Detmar SB; Enzing CM; Hopkins MM; Gutierrez de Mesa E; Ibarreta D
    Pharmacogenomics; 2006 Jul; 7(5):783-92. PubMed ID: 16886902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-world clinical effectiveness, regulatory transparency and payer coverage: three ingredients for translating pharmacogenomics into clinical practice.
    Frueh FW
    Pharmacogenomics; 2010 May; 11(5):657-60. PubMed ID: 20415556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Facilitating secondary use of medical data by using openEHR archetypes.
    Kohl CD; Garde S; Knaup P
    Stud Health Technol Inform; 2010; 160(Pt 2):1117-21. PubMed ID: 20841857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-centric universal pseudonymisation for secondary use of the EHR.
    Lo Iacono L
    Stud Health Technol Inform; 2007; 126():239-47. PubMed ID: 17476066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-justifying electronic medical records.
    Renner K
    Healthc Financ Manage; 1996 Oct; 50(10):63-4, 66, 68 passim. PubMed ID: 10161725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On pharmacogenomics in pharmacy benefit management.
    Russell Teagarden J; Stanek EJ
    Pharmacotherapy; 2012 Feb; 32(2):103-11. PubMed ID: 22392418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating pharmacogenomics into drug development.
    Ferentz AE
    Pharmacogenomics; 2002 Jul; 3(4):453-67. PubMed ID: 12164770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Has your organization leveraged the benefits of a computerized patient record?
    Davis D; LeMaistre A
    Nurs Case Manag; 1997; 2(6):240-5. PubMed ID: 9481312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
    Smart A; Martin P
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.